NBIX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

NBIXNeurocrine Biosciences Inc

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

NBIXNeurocrine Biosciences Inc

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

NBIXNeurocrine Biosciences Inc

164.56▲+3.01%· post 164.56

Mkt cap$16.7BRevenue$1.1BQ3 FY26Revenue$2.9BFY25

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

ClosedNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 6 '26

NBIXNeurocrine Biosciences Inc

AMGNAmgen Inc

164.56▲+3.01%post 164.56

Price

460.55▲+0.06%post 460.42

$16.7B

Mkt cap

$249.0B

Q3 FY26$1.1B

Revenue

$10.4BQ3 FY26

FY25$2.9B

Revenue

$36.8BFY25

NBIX164.56▲+3.01%vsAMGN460.55▲+0.06%ClosedNov 6 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NBIX 9

ABBVAbbViesupplier

XENEXenon Pharmaceuticalssupplier

KRCKilroy Realtysupplier

MAZEMaze Therapeuticssupplier

5 more · NBIX chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›